No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr21:47485200-47517400 |
Weak transcription |
Right Atrium |
heart
|
2 |
chr21:47511400-47517600 |
Weak transcription |
Pancreas |
Pancrea
|
3 |
chr21:47513200-47517000 |
Weak transcription |
Aorta |
Aorta
|
4 |
chr21:47513200-47517200 |
Weak transcription |
HSMM |
muscle
|
5 |
chr21:47513200-47517200 |
Weak transcription |
HSMMtube |
muscle
|
6 |
chr21:47513400-47517000 |
Weak transcription |
Muscle Satellite Cultured Cells |
--
|
7 |
chr21:47513600-47517000 |
Weak transcription |
Primary T killer naive cells fromperipheralblood |
blood
|
8 |
chr21:47514600-47518800 |
Weak transcription |
Primary T killer memory cells from peripheral blood |
blood
|
9 |
chr21:47515000-47517000 |
Enhancers |
Spleen |
Spleen
|
10 |
chr21:47515000-47517200 |
Weak transcription |
Primary T helper naive cells from peripheral blood |
blood
|
11 |
chr21:47515400-47517000 |
Enhancers |
Right Ventricle |
heart
|
12 |
chr21:47515600-47517000 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
13 |
chr21:47515600-47517200 |
Transcr. at gene 5' and 3' |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
14 |
chr21:47516400-47517000 |
Enhancers |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|
15 |
chr21:47516400-47517000 |
Bivalent Enhancer |
Placenta |
Placenta
|
16 |
chr21:47516400-47517400 |
Flanking Active TSS |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
17 |
chr21:47516400-47517800 |
Flanking Active TSS |
Stomach Smooth Muscle |
stomach
|
18 |
chr21:47516400-47519600 |
Bivalent/Poised TSS |
Duodenum Smooth Muscle |
Duodenum
|
19 |
chr21:47516600-47517000 |
Flanking Active TSS |
Colon Smooth Muscle |
Colon
|
20 |
chr21:47516600-47517000 |
Weak transcription |
Ovary |
ovary
|
21 |
chr21:47516600-47517000 |
Flanking Bivalent TSS/Enh |
Rectal Smooth Muscle |
rectum
|
22 |
chr21:47516600-47517200 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Adipocyte Cultured Cells |
ES cell derived
|
23 |
chr21:47516600-47517200 |
Flanking Active TSS |
Adipose Derived Mesenchymal Stem Cell Cultured Cells |
ES cell derived
|
24 |
chr21:47516600-47517200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
25 |
chr21:47516600-47517200 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
26 |
chr21:47516600-47517200 |
Bivalent Enhancer |
Colonic Mucosa |
Colon
|
27 |
chr21:47516600-47517200 |
Flanking Active TSS |
NHDF-Ad |
bronchial
|
28 |
chr21:47516800-47517000 |
Transcr. at gene 5' and 3' |
IMR90 fetal lung fibroblasts Cell Line |
lung
|
29 |
chr21:47516800-47517000 |
Flanking Bivalent TSS/Enh |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
30 |
chr21:47516800-47517000 |
Flanking Active TSS |
Bone Marrow Derived Cultured Mesenchymal Stem Cells |
Bone marrow
|
31 |
chr21:47516800-47517000 |
Flanking Active TSS |
Adipose Nuclei |
Adipose
|
32 |
chr21:47516800-47517000 |
Flanking Active TSS |
Fetal Kidney |
kidney
|
33 |
chr21:47516800-47517000 |
Bivalent Enhancer |
Fetal Muscle Leg |
muscle
|
34 |
chr21:47516800-47517000 |
Enhancers |
Fetal Stomach |
stomach
|
35 |
chr21:47516800-47517000 |
Flanking Bivalent TSS/Enh |
Skeletal Muscle Female |
skeletal muscle
|
36 |
chr21:47516800-47517200 |
Flanking Bivalent TSS/Enh |
HUES6 Cell Line |
embryonic stem cell
|
37 |
chr21:47516800-47517200 |
Enhancers |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
38 |
chr21:47516800-47517200 |
Flanking Bivalent TSS/Enh |
Duodenum Mucosa |
Duodenum
|
39 |
chr21:47516800-47517200 |
Bivalent/Poised TSS |
Fetal Brain Male |
brain
|
40 |
chr21:47516800-47517200 |
Flanking Bivalent TSS/Enh |
Fetal Lung |
lung
|
41 |
chr21:47516800-47517200 |
Bivalent/Poised TSS |
Rectal Mucosa Donor 29 |
rectum
|
42 |
chr21:47516800-47517200 |
Bivalent/Poised TSS |
Rectal Mucosa Donor 31 |
rectum
|
43 |
chr21:47516800-47517400 |
Flanking Active TSS |
Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells |
embryonic stem cell
|
44 |
chr21:47516800-47517400 |
Flanking Active TSS |
Osteobl |
bone
|
45 |
chr21:47516800-47517600 |
Enhancers |
Primary T helper naive cells fromperipheralblood |
blood
|
46 |
chr21:47516800-47517600 |
Flanking Active TSS |
NH-A |
brain
|
47 |
chr21:47516800-47517600 |
Flanking Active TSS |
NHLF |
lung
|
48 |
chr21:47516800-47518000 |
Enhancers |
Lung |
lung
|
49 |
chr21:47516800-47518800 |
Bivalent/Poised TSS |
Skeletal Muscle Male |
skeletal muscle
|